Publicidad
Artículo original 30 de marzo de 2025

Artefacto por atenuación mamaria en Gated-SPECT de mujeres con probabilidad pre-test baja o intermedia de cardiopatía isquémica

Referenciar Imprimir Descargar PDF

Referencias

  1. Judelson DR. Examining the gender bias in evaluating coronary disease in women. Medscape Womens Health 1997; 2:5.
  2. Hung J, Chaitman BR, Lam J, et al. Noninvasive diagnostic test choices for the evaluation of coronary artery disease in women: a multivariate comparison of cardiac fluoroscopy, exercise electrocardiography and exercise thallium myocardial perfusion scintigraphy. J Am Coll Cardiol 1984; 4:8-16.
  3. Stinis CT, Lizotte PE, Movahed M-R. Impaired myocardial SPECT imaging secondary to silicon- and saline-containing breast implants. Int J Cardiovasc Imaging 2006; 22:449-55.
  4. Hansen CL, Sundaram S. The ratio of the apex/anterior wall: A marker of breast attenuation artifact in women: Nucl Med Commun 2006; 27:803-6.
  5. Goodgold HM, Rehder JG, Samuels LD, Chaitman BR. Improved interpretation of exercise Tl-201 myocardial perfusion scintigraphy in women: characterization of breast attenuation artifacts. Radiology 1987; 165:361-6.
  6. Acevedo M, Varleta P. Exámenes diagnósticos cardiovasculares: ¿diferencias de género en su interpretación? Rev Colomb Cardiol 2018; 25:66-72.
  7. Taillefer R, DePuey EG, Udelson JE, et al. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997; 29:69-77.
  8. Botvinick EH. Breast attenuation artifacts in Tl-201 scintigraphy. Radiology 1988; 168:878-9.
  9. Garver PR, Wasnich RD, Shibuya AM, Yeh F. Appearance of breast attenuation artifacts with thallium myocardial SPECT imaging. Clin Nucl Med1985; 10:694-6.
  10. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979; 300:1350-8.
  11. Holly TA, Abbott BG, Al-Mallah M, et al. Single photon-emission computed tomography. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol 2010; 17:941-73.
  12. Task Force Members, Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013; 34:2949-3003.
  13. Arósa F, Boraita A, Alegría E, et al. Guías de práctica clínica de la Sociedad Española de Cardiología en pruebas de esfuerzo. Rev Esp Cardiol 2000; 53:1063-94.
  14. Alexiou S, Georgoulias P, Angelidis G, et al. Myocardial perfusion and left ventricular quantitative parameters obtained using gated myocardial SPECT: Comparison of three software packages. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol 2018; 25:911-24.
  15. Romero-Farina G, Candell-Riera J, Aguadé-Bruix S, et al. Predictive variables for hard cardiac events and coronary revascularization in patients with normal left ventricular myocardial perfusion and systolic function. Eur J Nucl Med Mol Imaging 2013; 40:1181-9.
  16. Wenger NK. Clinical presentation of CAD and myocardial ischemia in women. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol 2016; 23:976-85.
  17. Sörensen NA, Neumann JT, Ojeda F, et al. Relations of sex to diagnosis and outcomes in acute coronary syndrome. J Am Heart Assoc 2018; 7:e007297.
  18. Hendel R, Ficaro E, Williams K. Timeliness of reporting results of nuclear cardiology procedures. J Nucl Cardiol 2007; 14:266.
  19. Corbett JR, Kritzman JN, Ficaro EP. Attenuation correction for single photon emission computed tomography myocardial perfusion imaging. Curr Cardiol Rep 2004; 6:32-40.
  20. Hendel RC, Cerqueira M, Douglas PS, et al. A Multicenter assessment of the use of single-photon emission computed tomography myocardial perfusion imaging with appropriateness criteria. J Am Coll Cardiol 2010; 55:156-62.
  21. Hendel RC, Abbott BG, Bateman TM, et al. The role of radionuclide myocardial perfusion imaging for asymptomatic individuals. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol 2011; 18:3-15.
  22. Ficaro EP, Fessler JA, Ackermann RJ, et al. Simultaneous transmission-emission Thallium 201 cardiac SPECT: Effect of attenuation correction on myocardial tracer distribution. J Nucl Med 1995; 36:921-31.
  23. Joonki Noh, Fessler JA, Kinahan PE. Statistical sinogram restoration in dual-energy CT for PET attenuation correction. IEEE Trans Med Imaging 2009; 28:1688-702.
  24. Malek H, Yaghoobi N, Hedayati R. Artifacts in quantitative analysis of myocardial perfusion SPECT using Cedars-Sinai QPS software. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol 2017; 24:534-42.
  25. Liu C-J, Cheng J-S, Chen Y-C, et al. A performance comparison of novel cadmium–zinc–telluride camera and conventional SPECT/CT using anthropomorphic torso phantom and water bags to simulate soft tissue and breast attenuation. Ann Nucl Med 2015; 29:342-50.
  26. Sharma P, Patel CD, Karunanithi S, et al. Comparative accuracy of CT attenuation-corrected and non–attenuation-corrected SPECT myocardial perfusion imaging: Clin Nucl Med 2012; 37:332-8.
  27. Gutstein A, Bental T, Solodky A, et al. Prognosis of stress-only SPECT myocardial perfusion imaging with prone imaging. J Nucl Cardiol 2018; 25:809-16.
  28. DePuey EG, Rozanski A. Using gated Technetium-99m-Sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med 1995; 36:952-5.
  29. Chatziioannou SN. Gating of myocardial perfusion imaging for the identification of artifacts. Tex Heart Inst J 2000; 27:5.